What is it about?
Chronic refractory cough (CRC) is a cough that last eight weeks or longer, has no known cause, and/or does not respond to typical cough treatments. CRC is commonly treated with behavioral cough suppression therapy (BCST), which involves cough education, voice hygiene, cough suppression techniques, and psychoeducational counseling. In previous literature, chronic cough patients have been shown to have elevated anxiety. This study assesses the potential prevalence of anxiety in CRC patients and its possible role in treatment outcomes.
Featured Image
Photo by Towfiqu barbhuiya on Unsplash
Why is it important?
Our findings show that anxiety may be a prevalent comorbidity in patients with chronic refractory cough, and those with anxiety may respond greater to behavioral cough suppression therapy than those without anxiety.
Perspectives
I hope this article brings attention to factors that may be affecting treatment outcomes in patients with chronic refractory cough. It is important that providers treating this patient population look at the patient holistically and account for the entire picture in treatment.
Miranda Wright
University of Utah
Read the Original
This page is a summary of: Prevalence of Anxiety as a Variable in Treatment Outcomes for Individuals With Chronic Refractory Cough, American Journal of Speech-Language Pathology, December 2023, American Speech-Language-Hearing Association (ASHA),
DOI: 10.1044/2023_ajslp-23-00104.
You can read the full text:
Contributors
The following have contributed to this page
